Active Not Recruiting NCT07047651
This summary needs review. Please check the official study record and contact the research team for details.
In Athens Why is this study shown? This study includes Bipolarity among several conditions.
Schizophrenia, Bipolarity Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries Greece
Sponsor Dr. Stavroula Rakitzi
Condition Schizophrenia, Bipolarity Completed NCT00188942
This summary needs review. Please check the official study record and contact the research team for details.
In Toronto Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity Drug From 18 Years to 55 Years
Countries Canada
Sponsor University Health Network, Toronto
Condition Depression, Bipolarity Terminated NCT03643159
This study was terminated in the United States. It focuses on depression.
Multiple locations, including Santa Rosa Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity, ... Drug From 18 Years to 63 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Depression, Bipolarity, ... Completed NCT03386851
This summary needs review. Please check the official study record and contact the research team for details.
In Gwangju Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Schizophrenia Observational i A study where researchers collect information without assigning a treatment. Over 19 Years
Countries South Korea
Sponsor Korea Otsuka Pharmaceutical Co., Ltd.
Condition Bipolarity, Schizophrenia Completed NCT01028196
This study is completed in Russia. It is testing bipolarity Symptoms for depression.
Multiple locations, including Chita Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression, ... Observational From 18 Years to 65 Years
Countries Russia
Sponsor AstraZeneca
Condition Bipolarity, Depression, ... Completed NCT02050854
This study is completed in the United States. It is testing pharmacokinetics of Aripiprazole for schizophrenia.
Multiple locations, including Garden Grove Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Schizophrenia Observational From 18 Years to 55 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Bipolarity, Schizophrenia Not recruiting ISRCTN95702682
This study is not recruiting in the United Kingdom. It focuses on schizophrenia.
In United Kingdom Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Schizophrenia Other From 18 Years to 110 Years
Countries United Kingdom
Sponsor Birmingham and Solihull Mental Health Foundation Trust
Condition Bipolarity, Schizophrenia Completed NCT00001483
This summary needs review. Please check the official study record and contact the research team for details.
In Bethesda Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity Drug
Countries United States
Sponsor National Institute of Mental Health (NIMH)
Condition Depression, Bipolarity Not recruiting ISRCTN56908625
This study is looking at whether 1 can help people with bipolarity. Participants take part in 1 and complete follow-up assessments.
In United Kingdom Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity Other Over 18 Years
Countries United Kingdom
Sponsor Lancaster University (UK)
Condition Bipolarity Not recruiting ISRCTN32290525
This study is looking at whether a digital support tool can help people with bipolarity. Participants take part in the program and complete follow-up questionnaires or assessments.
In United Kingdom Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity Other Over 18 Years
Countries United Kingdom
Sponsor King's College London (UK)
Condition Bipolarity Not recruiting ISRCTN28588282
This study is not recruiting in France. It is testing agomelatine given orally compared to placebo, for depression.
In France Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity Other Over 18 Years
Countries France
Sponsor Institut de Recherches Internationales Servier (France)
Condition Depression, Bipolarity Not recruiting ISRCTN59769322
This study is looking at whether psychoeducation can help people with Topic: Mental Health Research Network, Subtopic: Bipolarity, Disease: Bipolarity, or Mental and Behavioural Disorders. Participants take part in psychoeducation and complete follow-up assessments.
In United Kingdom Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity Other From 11 Years to 18 Years
Countries United Kingdom
Sponsor Northumberland, Tyne and Wear NHS Foundation Trust (UK)
Condition Bipolarity